Denise Peterson
Editor-in-Chief, Regulatory & Policy Insights
Denise oversees a global group of journalists covering biopharma regulatory and policy news and trends, primarily published the Pink Sheet. She also teams up with colleagues on strategic content initiatives affecting multiple Citeline publications as well as recruiting, training, website enhancements and collaborations with sales and marketing.
She has had a colorful history as a reporter and senior editor on predecessor publications to Citeline’s current offerings, including "The Pink Sheet", "The Blue Sheet" (NIH and public health programs), "The Beige Sheet" (medical technology reimbursement) and Medicare Drug Focus. Her areas of particular expertise include Capitol Hill and health care reimbursement. Outside of the office, her interests include culinary history and she is a long-time literacy volunteer.
Latest From Denise Peterson
Maureen Kenny, 1963-2022
Kenny, a mainstay of our publications for three decades, has passed away in London.
Maureen Kenny, 1963-2022
Kenny, a mainstay of our publications for three decades, has passed away in London.
Maureen Kenny, 1963-2022
Kenny, a mainstay of our publications for three decades, has passed away in London.
Q4 Editor’s Picks: Clinical Trial Regulation
Coverage of clinical trial policy included commentary on rapid growth of the PD-1 pipeline by both US and China regulators; case studies and discussion of trial strategies including RWE, pediatric studies and decentralized trials; and US FDA commissioner-nominee Robert Califf’s R&D expertise.
Editor's Note: Please Help Pink Sheet Serve You Best
Please take our brief reader survey to help us better understand your content and delivery needs.
Editor’s Choice: Notable Pink Sheet Articles From Q3
A must-read selection of intriguing and popular articles posted in the Pink Sheet over the past three months.